BR9809491A - "derivados de ergolina e seu uso como antagonista de receptor de somatostatina" - Google Patents

"derivados de ergolina e seu uso como antagonista de receptor de somatostatina"

Info

Publication number
BR9809491A
BR9809491A BR9809491-2A BR9809491A BR9809491A BR 9809491 A BR9809491 A BR 9809491A BR 9809491 A BR9809491 A BR 9809491A BR 9809491 A BR9809491 A BR 9809491A
Authority
BR
Brazil
Prior art keywords
somatostatin receptor
receptor antagonist
ergoline derivatives
formula
ergoline
Prior art date
Application number
BR9809491-2A
Other languages
English (en)
Inventor
Paul Pfaeffli
Peter Neumann
Robert Swoboda
Peter Stuetz
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of BR9809491A publication Critical patent/BR9809491A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D457/00—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid
    • C07D457/04—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 8
    • C07D457/06—Lysergic acid amides
    • C07D457/08—Lysergic acid amides in which the amide nitrogen is a member of a heterocyclic ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurosurgery (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Pain & Pain Management (AREA)
  • Psychology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

Patente de Invenção: <B>"DERIVADOS DE ERGOLINA E SEU USO COMO ANTAGONISTAS DE RECEPTOR DE SOMATOSTATINA"<D>. A invenção propicia compostos de fórmula I onde R~ 1~ a R~ 6~ são como definidos na descrição, e um processo para prepará-los. Os compostos de fórmula I são úteis como produtos farmacêuticos.
BR9809491-2A 1997-05-29 1998-05-27 "derivados de ergolina e seu uso como antagonista de receptor de somatostatina" BR9809491A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9711043.1A GB9711043D0 (en) 1997-05-29 1997-05-29 Organic compounds
PCT/EP1998/003125 WO1998054183A2 (en) 1997-05-29 1998-05-27 Ergoline derivatives and their use as somatostatin receptor antagonists

Publications (1)

Publication Number Publication Date
BR9809491A true BR9809491A (pt) 2000-10-17

Family

ID=10813201

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9809491-2A BR9809491A (pt) 1997-05-29 1998-05-27 "derivados de ergolina e seu uso como antagonista de receptor de somatostatina"

Country Status (24)

Country Link
US (1) US6221870B1 (pt)
EP (1) EP0986558A2 (pt)
JP (1) JP2001527580A (pt)
KR (1) KR20010013103A (pt)
CN (1) CN1259946A (pt)
AR (1) AR012870A1 (pt)
AU (1) AU727841B2 (pt)
BR (1) BR9809491A (pt)
CA (1) CA2288810A1 (pt)
CO (1) CO4950561A1 (pt)
CZ (1) CZ289466B6 (pt)
GB (1) GB9711043D0 (pt)
HU (1) HUP0002311A3 (pt)
ID (1) ID22916A (pt)
IL (1) IL132571A0 (pt)
NO (1) NO995482D0 (pt)
NZ (1) NZ500386A (pt)
PE (1) PE74899A1 (pt)
PL (1) PL336502A1 (pt)
RU (1) RU2191776C2 (pt)
SK (1) SK160899A3 (pt)
TR (1) TR199902848T2 (pt)
WO (1) WO1998054183A2 (pt)
ZA (1) ZA984560B (pt)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070243240A9 (en) * 2000-08-24 2007-10-18 Fred Windt-Hanke Transdermal therapeutic system
DE10341317B4 (de) * 2003-09-03 2008-10-23 Axxonis Pharma Ag Transdermales therapeutisches System (TTS) zur Verabreichung von Ergolinverbindungen ausgenommen Pergolid
DE10053397A1 (de) * 2000-10-20 2002-05-02 Schering Ag Verwendung eines dopaminergen Wirkstoffes zur Behandlung von dopaminerg behandelbaren Erkrankungen
DE10066158B4 (de) * 2000-08-24 2007-08-09 Neurobiotec Gmbh Verwendung eines transdermalen therapeutischen Systems zur Behandlung des Restless-Legs-Syndroms
PT2062914E (pt) * 2001-06-08 2014-07-18 Ipsen Pharma Sas Análogos quiméricos de somatostatina-dopamina
FI20031454A0 (fi) 2003-10-06 2003-10-06 Juvantia Pharma Ltd Oy Selektiivisiä somatostatiinireseptori 1 ja/tai 4 -agonisteja ja -antagonisteja
KR101000923B1 (ko) * 2004-01-08 2010-12-13 삼성전자주식회사 원격 제어기의 매크로 설정 장치 및 방법
US20100048549A1 (en) * 2005-05-18 2010-02-25 Siegfried Wurster Peptidomimetics selective for the somatostatin receptor subtypes 1 and/or 4
JP2007067096A (ja) * 2005-08-30 2007-03-15 Fujitsu Ltd 半導体装置
WO2011079313A1 (en) * 2009-12-23 2011-06-30 Map Pharmaceuticals, Inc. Novel ergoline analogs
US8604035B2 (en) 2011-06-23 2013-12-10 Map Pharmaceuticals, Inc. Fluoroergoline analogs
WO2013095707A1 (en) 2011-12-19 2013-06-27 Map Pharmaceuticals, Inc. Novel iso-ergoline derivatives
EP2793583A4 (en) 2011-12-21 2015-08-12 Map Pharmaceuticals Inc NOVEL NEUROMODULATORY CONNECTIONS
US9012640B2 (en) 2012-06-22 2015-04-21 Map Pharmaceuticals, Inc. Cabergoline derivatives
TWI523863B (zh) 2012-11-01 2016-03-01 艾普森藥品公司 體抑素－多巴胺嵌合體類似物
JP2016503402A (ja) 2012-11-01 2016-02-04 イプセン ファルマ ソシエテ パール アクシオン サンプリフィエＩｐｓｅｎ Ｐｈａｒｍａ Ｓ．Ａ．Ｓ． ソマトスタチン類似体及びそのダイマー
CN107428745A (zh) 2015-01-20 2017-12-01 Xoc制药股份有限公司 麦角灵化合物及其用途
JP2018502889A (ja) 2015-01-20 2018-02-01 エックスオーシー ファーマシューティカルズ インコーポレイテッドＸｏｃ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ， Ｉｎｃ イソエルゴリン化合物およびその使用
WO2018223065A1 (en) 2017-06-01 2018-12-06 Xoc Pharmaceuticals, Inc. Ergoline derivatives for use in medicine
JP7099717B2 (ja) 2019-09-30 2022-07-12 株式会社理研バイオ ソマトスタチン受容体

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH475252A (de) * 1966-02-08 1969-07-15 Sandoz Ag Verfahren zur Herstellung neuer Lysergsäure-Derivate
US3592816A (en) 1966-02-08 1971-07-13 Sandoz Ltd N-substituted piperazides of lysergic acid
GB1188197A (en) 1967-10-11 1970-04-15 Sandoz Ltd Lysergic Acid Derivatives
NL6818658A (pt) * 1968-01-18 1969-07-22
GB1580448A (en) * 1976-12-06 1980-12-03 Farmaceutici Italia 8 -acetyl-6-methyl-ergoline i derivatives
GB8501078D0 (en) * 1985-01-16 1985-02-20 Erba Farmitalia Piperazin-1-yl-ergo-line derivatives
TW357143B (en) 1995-07-07 1999-05-01 Novartis Ag Benzo[g]quinoline derivatives

Also Published As

Publication number Publication date
PL336502A1 (en) 2000-07-03
ID22916A (id) 1999-12-16
NZ500386A (en) 2002-05-31
ZA984560B (en) 1998-11-30
CA2288810A1 (en) 1998-12-03
PE74899A1 (es) 1999-09-14
US6221870B1 (en) 2001-04-24
GB9711043D0 (en) 1997-07-23
HUP0002311A3 (en) 2002-08-28
AU727841B2 (en) 2001-01-04
CZ289466B6 (cs) 2002-01-16
WO1998054183A2 (en) 1998-12-03
EP0986558A2 (en) 2000-03-22
NO995482L (no) 1999-11-09
IL132571A0 (en) 2001-03-19
JP2001527580A (ja) 2001-12-25
AR012870A1 (es) 2000-11-22
NO995482D0 (no) 1999-11-09
HUP0002311A2 (hu) 2000-12-28
CO4950561A1 (es) 2000-09-01
TR199902848T2 (xx) 2000-02-21
SK160899A3 (en) 2000-07-11
CN1259946A (zh) 2000-07-12
CZ424599A3 (cs) 2000-03-15
WO1998054183A3 (en) 1999-03-04
RU2191776C2 (ru) 2002-10-27
KR20010013103A (ko) 2001-02-26
AU8210898A (en) 1998-12-30

Similar Documents

Publication Publication Date Title
BR9809491A (pt) &#34;derivados de ergolina e seu uso como antagonista de receptor de somatostatina&#34;
BR9803179A (pt) Antagonistas receptores de ccr-3.
BR0015963A (pt) Compostos de uréia antagonistas receptor muscarìnico, composições farmacêuticas compreendendo tais compostos e método de preparação destes compostos
BR0014973A (pt) Heterociclos de nitrogênio bicìclico de alquilamino substituìdo como inibidores de proteìna quinase p38
BR0306150A (pt) Composto, uso de um composto, e, composição farmacêutica
BRPI0215312B8 (pt) composto, uso de um composto, composição farmacêutica, e processo para a preparação de um composto
TR200101398T2 (tr) Pirolidin türevleri-CCR-3 reseptörü antagonistleri.
BR9812944A (pt) Inibidores bicìclicos da cinase
BRPI9811688B1 (pt) benzamidas bicìclicas gastrocinéticas de derivados de piperidina 3- ou 4- substituìdos com 4-aminometil), processo para preparação das mesmas, composições farmacêuticas compreendendo as mesmas e processo para preparação das referidas composições.
BRPI0314325B8 (pt) derivados de aza-bicicloalquila, seu uso, seu processo de preparação e composição farmacêutica que os compreende
ES2159738T3 (es) Derivados de benzamida y su uso como antagonistas de vasopresina.
BR0107888A (pt) Pirrolidinas 1,3-dissubstituidas como antagonistas de alfa-2adrenorreceptor
EA200200360A1 (ru) Производные пурина
BR9810829B1 (pt) composto heterocìclico, processo para preparar o mesmo, composição farmacêutica, e, uso de um composto ou de uma composição farmacêutica.
PT1007523E (pt) Derivados indole e 2,3-di-ridroindole, sua preparacao e utilizacao
BR9909739A (pt) Benzotiadiazóis e derivados
BR0011831A (pt) Compostos, processo para preparar os mesmos, composições farmacêuticas, e, uso dos compostos
ES2178055T3 (es) Derivados aminicos substituidos, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.
GR3025948T3 (en) Heterocyclic alkylamines, process for their preparation and pharmaceutical compositions containing them
BR9801150A (pt) Derivados de propanolamina, processos para a preparação deles, produtos farmacêuticos compreendendo esses compostos e uso dos mesmos.
BR9909486A (pt) Compostos calcilìticos
BRPI0418255A (pt) derivados de piperazina e piperidina n-substituìdos
BR9907934A (pt) Composto, composição farmacêutica, e, processo para a preparação do composto
HUP0101143A3 (en) Pyridin-carboxylic acid derivatives as vitronectin receptor antagonists, process for producing them and pharmaceutical compositions containing them
HUP0200281A2 (en) Heterocyclic benzenesulphonamide compounds as bradykinine antagonists, process for their preparation and pharmaceutical compositions containing them

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 6O,7O,8O E 9O ANUIDADES

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 1909 DE 07/08/2007.